In collaboration with the BioInnovation Institute (BII), AAAS is saying the institution of the BII & Science Translational Medication Prize for Improvements in Ladies’s Well being. Submissions at the moment are open for the primary yr of the prize, which will probably be awarded in 2025.
The brand new award will intention to acknowledge and elevate scientists who’ve made excellent analysis discoveries which have translational potential to impression ladies’s well being around the globe.
Related analysis subjects embody, however aren’t restricted to, investigation into maternal well being and gynecological circumstances, areas of reproductive well being similar to infertility, or analysis into sex- and gender-specific approaches to circumstances that have an effect on ladies disproportionately.
The prize will spotlight researchers who’ve made contributions to addressing questions in these fields, in addition to scientists creating new diagnostics, medicine, and medical gadgets with translational impression. Investigators engaged on options that may be readily deployed to underserved populations in low- and middle-income international locations are additionally welcome to use.
“Translational ladies’s well being analysis wanted to enhance the well being of girls around the globe has been under-valued,” stated Sudip Parikh, chief government officer of AAAS. “This high-profile prize is meant to catalyze, develop, and prioritize this vital but under-funded analysis.”
Researchers from any gender, age, and profession stage are inspired to use. All candidates will submit a 1,000-word essay detailing their most vital analysis discoveries and the translational implications of their work for girls’s well being.
The prize winner will obtain a money prize of $25,000. The winner will even have their essay printed in Science Translational Medication and can obtain a 5-year digital subscription to the journal.
As well as, the winner could have the chance to current their award-winning findings for an viewers on the prize ceremony in Denmark in Might of 2025. They will even have the possibility to be paired with the enterprise growth group from BII to judge their eligibility for any of BII’s assist packages.
The deadline for all submissions is November 1, 2024. Directions for how you can apply for the prize might be discovered right here.
Science Translational Medication is delighted to be partnering with the BioInnovation Institute on a brand new annual prize that can honor main analysis advances and improvements that deal with unmet wants within the essential space of girls’s well being.”
Orla Smith, Editor of Science Translational Medication
The prize is funded by BII, a global non-profit basis that gives early-stage funding and enterprise growth assist to researchers and entrepreneurs working within the life sciences. The muse presently runs the Ladies’s Well being Initiative, a program that fosters start-ups and initiatives concerned in ladies’s well being.
That is the second prize on which the Science household of journals has partnered with BII. The BioInnovation Institute & Science Prize for Innovation – first awarded in 2022 – seeks to reward scientists who ship analysis on the intersection of the life sciences and entrepreneurship.
“We’re proud to introduce this Prize, following the success of our Innovation Prize. Ladies’s Well being stays a core focus for BII, as we proceed to assist early-stage start-ups and initiatives within the discipline, and we hope this award offers the well-deserved recognition of the researchers main the way in which on this undeserved space of analysis,” stated Jens Nielsen, chief government officer at BioInnovation Institute (BII).